Back to News
Market Impact: 0.1
Hemab Therapeutics Strengthens Board of Directors with Appointment of Keli Walbert
Source: GlobeNewswire
Management & Governance
Keli Walbert has joined the company’s board, bringing roughly two decades of commercial leadership and experience with product launches. The announcement provides no financial details, strategic changes, or guidance and is unlikely to materially affect valuation.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- Nasdaq defies Nvidia impact as Huang faces espionage affair probe
- Jensen Huang’s $21 billion net worth in AI rout—Nvidia’s recovery will be ‘capped’ after he admitted affair with alleged Chinese spy
- Nvidia's CEO turmoil gives newly empowered Democrats fresh ammunition in pursuit of oversight
- UniCredit CEO Plots Commerzbank Governance Overhaul
- Why is Nvidia’s Jensen Huang at the centre of a US-China spy scandal?
- Stocks Rise as Investors Shrug Off Nvidia Probe; Trump Says Iran Strikes Unlikely